Mayr M - Search Results

1

Capecitabine for treatment of advanced hepatocellular carcinoma.

von Delius S, Lersch C, Mayr M, Stock K, Schulte-Frohlinde E, Schmid RM, Eckel F. von Delius S, et al. Among authors: mayr m. Hepatogastroenterology. 2007 Dec;54(80):2310-4. Hepatogastroenterology. 2007. PMID: 18265654

2

Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma.

Eckel F, von Delius S, Mayr M, Dobritz M, Fend F, Hosius C, Schleyer E, Schulte-Frohlinde E, Schmid RM, Lersch C. Eckel F, et al. Among authors: mayr m. Oncology. 2005;69(5):363-71. doi: 10.1159/000089990. Epub 2005 Nov 24. Oncology. 2005. PMID: 16319507 Clinical Trial.

3

Phase II trial of a 24-hour infusion of gemcitabine in previously untreated patients with advanced pancreatic adenocarcinoma.

Eckel F, Schmelz R, Erdmann J, Mayr M, Lersch C. Eckel F, et al. Among authors: mayr m. Cancer Invest. 2003;21(5):690-4. doi: 10.1081/cnv-120023767. Cancer Invest. 2003. PMID: 14628426 Clinical Trial.

4

Phase II trial of weekly 24-hour infusion of gemcitabine in patients with advanced gallbladder and biliary tract carcinoma.

von Delius S, Lersch C, Schulte-Frohlinde E, Mayr M, Schmid RM, Eckel F. von Delius S, et al. Among authors: mayr m. BMC Cancer. 2005 Jun 12;5:61. doi: 10.1186/1471-2407-5-61. BMC Cancer. 2005. PMID: 15949047 Free PMC article. Clinical Trial.

5

Carbamazepine for prevention of oxaliplatin-related neurotoxicity in patients with advanced colorectal cancer: final results of a randomised, controlled, multicenter phase II study.

von Delius S, Eckel F, Wagenpfeil S, Mayr M, Stock K, Kullmann F, Obermeier F, Erdmann J, Schmelz R, Quasthoff S, Adelsberger H, Bredenkamp R, Schmid RM, Lersch C. von Delius S, et al. Among authors: mayr m. Invest New Drugs. 2007 Apr;25(2):173-80. doi: 10.1007/s10637-006-9010-y. Epub 2006 Sep 13. Invest New Drugs. 2007. PMID: 16983507 Clinical Trial.

6

Pancreatic cancer and depression: myth and truth.

Mayr M, Schmid RM. Mayr M, et al. BMC Cancer. 2010 Oct 20;10:569. doi: 10.1186/1471-2407-10-569. BMC Cancer. 2010. PMID: 20961421 Free PMC article.

7

Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma.

Mayr M, Becker K, Schulte N, Belle S, Hofheinz R, Krause A, Schmid RM, Röcken C, Ebert MP. Mayr M, et al. BMC Cancer. 2012 Dec 10;12:587. doi: 10.1186/1471-2407-12-587. BMC Cancer. 2012. PMID: 23228190 Free PMC article. Clinical Trial.

8

Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer.

Lersch C, Schmelz R, Eckel F, Erdmann J, Mayr M, Schulte-Frohlinde E, Quasthoff S, Grosskreutz J, Adelsberger H. Lersch C, et al. Among authors: mayr m. Clin Colorectal Cancer. 2002 May;2(1):54-8. doi: 10.3816/CCC.2002.n.011. Clin Colorectal Cancer. 2002. PMID: 12453338

9

Interleukin 1 beta gene promoter SNPs are associated with risk of pancreatic cancer.

Hamacher R, Diersch S, Scheibel M, Eckel F, Mayr M, Rad R, Bajbouj M, Schmid RM, Saur D, Schneider G. Hamacher R, et al. Among authors: mayr m. Cytokine. 2009 May;46(2):182-6. doi: 10.1016/j.cyto.2009.01.005. Epub 2009 Feb 28. Cytokine. 2009. PMID: 19251436

10

Depression in pancreatic cancer: sense of impending doom.

Mayr M, Schmid RM. Mayr M, et al. Digestion. 2010;82(1):1-3. doi: 10.1159/000272422. Epub 2010 Feb 9. Digestion. 2010. PMID: 20145401 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

621 results

Search Page

Filters